Dietary Hemp Breakthrough Cannaka Announced

Introducing Cannaka™, a breakthrough all natural, safe, non-intoxicating, botanically complete dietary hemp extract that helps unlock the body's innate healing abilities, promotes a healthy inflammatory response, boosts energy, promotes focus, and encourages a sense of well-being.

Del Mar, California (prnob) October 21, 2015 - "The Strause Group is proud to announce an important scientific breakthrough: Cannaka™, a complex of dietary hemp cannabinoids (CBDs) that help unlock the body's innate healing abilities, promote a healthy inflammatory response, boost energy, promote focus, and encourage a sense of well-being," says Tyler Strause, president.

"The healthful properties of hemp have been known for millennia, but this is the first time a safe, all natural, non-toxic, non-intoxicating, botanically complete extract that complies with all state and federal regulations has been offered as a nutraceutical supplement like vitamins and herbs. Cannaka is a water soluble, isotonic nano-emulsion extracted using a supercritical CO2 process that leaves behind no residues or potentially harmful by-products."

"Cannaka is causing a considerable stir throughout the broad world of inflammatory disease treatment," says Strause. "The applications are unlimited. Cannaka is useful in mitigating symptoms of countless inflammatory and mood disorders. At the moment, Cannaka is available as an additive and as a soothing, deep-acting skin cream. However, many products powered by Cannaka are now in development that will help enhance quality of life by supporting the central nervous system and cellular rejuvenation."

Cannaka engages the endocannabinoid system (ECS), a scientifically proven system of receptors throughout the body. The ECS is the largest system of "neuromodulators" in the body, binding to over a hundred cannabinoids. Cannaka contains CBD terpenes, those aromatic cannabinoids (in particular. the active ingredient beta-caryophyllene) that catalyze the synergy of hemp compounds to produce the documented "entourage effect," by which CBD benefits are multiplied into greater local and systemic responses to an abundance of disorders including inflammation. Cannaka is recommended as a complement to physician prescribed medical treatments and pharmaceuticals.

Cannaka is the product that the Strause family wished it had when providing intensive end of life care for Randy Strause, husband of Linda (a PhD Professor of Human Nutrition at UC San Diego, scholar, and clinical researcher with over 25 years' experience as one of the top in her field), and sons Tyler, (a visionary scientist and subject matter expert) and Brendon (a businessman).

"Our dad found relief in medical marijuana for glioblastoma multiforme, a deadly type of brain cancer," says Tyler Strause. "Upon his passing in 2010, we wanted to help others by providing what we did for him but without the stigma or side effects. Ours was a transformative odyssey that resulted in the development of extraordinary new products. As a result, Cannaka is both a cause and a movement that is becoming a quality of life industry resulting from our family's journey born out of love."

NB: The information provided in this press release is for general informational purposes and published on PRnob only.